Proteomic Analysis of Complement Proteins in Glomerular Diseases.

[1]  F. Emma,et al.  Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients. , 2020, Kidney international.

[2]  D. Cattran,et al.  Proteomic Analysis of Complement Proteins in Membranous Nephropathy , 2020, Kidney international reports.

[3]  M. Jadoul,et al.  Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. , 2020, Kidney international.

[4]  S. Meri,et al.  Complement dysregulation in glomerulonephritis. , 2019, Seminars in immunology.

[5]  T. Nadasdy,et al.  Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis , 2019, Nature Reviews Nephrology.

[6]  U. Specks,et al.  Exostosin 1/Exostosin 2-Associated Membranous Nephropathy. , 2019, Journal of the American Society of Nephrology : JASN.

[7]  Richard J. H. Smith,et al.  C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic , 2018, Mayo Clinic proceedings.

[8]  V. D’Agati,et al.  The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases. , 2018, Journal of the American Society of Nephrology : JASN.

[9]  Agnes B. Fogo,et al.  Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. , 2018, Kidney international.

[10]  Sanjeev Sethi,et al.  DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN. , 2017, Journal of the American Society of Nephrology : JASN.

[11]  S. Rodríguez de Córdoba,et al.  Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy. , 2017, Kidney international.

[12]  M. Falchi,et al.  Circulating complement factor H–related proteins 1 and 5 correlate with disease activity in IgA nephropathy , 2017, Kidney international.

[13]  Richard J. H. Smith,et al.  Characterization of C3 in C3 glomerulopathy , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  Jai Radhakrishnan,et al.  Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. , 2016, Journal of the American Society of Nephrology : JASN.

[15]  C. Kallenberg,et al.  Complement system activation in ANCA vasculitis: A translational success story? , 2015, Molecular immunology.

[16]  V. D’Agati,et al.  Bacterial infection-related glomerulonephritis in adults. , 2013, Kidney international.

[17]  F. Cosio,et al.  Immunotactoid glomerulopathy: clinicopathologic and proteomic study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  S. Nasr,et al.  Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosis , 2012, Kidney international.

[19]  V. D’Agati,et al.  Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[20]  L. Hebert,et al.  Infection-related glomerulonephritis: understanding mechanisms. , 2011, Seminars in nephrology.

[21]  S. Nasr,et al.  Fibrillary glomerulonephritis: a report of 66 cases from a single institution. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[22]  Richard J. H. Smith,et al.  Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[23]  H. R. Bergen,et al.  Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. , 2009, Blood.

[24]  Sandrine Florquin,et al.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. , 2009, Kidney international.

[25]  V. D’Agati,et al.  Proliferative glomerulonephritis with monoclonal IgG deposits. , 2009, Journal of the American Society of Nephrology : JASN.

[26]  H. R. Bergen,et al.  Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. , 2009, Kidney international.

[27]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[28]  J. Reveille,et al.  The Molecular Basis of Complete Complement C4A and C4B Deficiencies in a Systemic Lupus Erythematosus Patient with Homozygous C4A and C4B Mutant Genes1 , 2002, The Journal of Immunology.

[29]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[30]  P. Kurtin,et al.  Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis. , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[32]  K. Reid,et al.  The proteolytic activation systems of complement. , 1981, Annual review of biochemistry.